Expression of endoplasmic reticulum oxidoreductase 1-α in cholangiocarcinoma tissues and its effects on the proliferation and migration of cholangiocarcinoma cells

References

• Sapisochín G, Sevilla EFD, Echeverri J, et al. Liver transplantation for cholangiocarcinoma current status and new insights J. World J Hepatol. 2015;7(22):2396–2403. doi:10.4254/wjh.v7.i22.239626464755
   PubMedGoogle Scholar
• Rizvi S, Gores GJ. Pathogenesis, diagnosis, and management of cholangiocarcinoma. Gastroenterology. 2013;145(6):1215–1229. doi:10.1053/j.gastro.2013.10.01324140396
   PubMed Web of Science ®Google Scholar
• Cardinale V, Semeraro R, Torrice A, et al. Intra-hepatic and extra-hepatic cholangiocarcinoma: new insight into epidemiology and risk factors. World J Gastrointest Oncol. 2010;2(11):407. doi:10.4251/wjgo.v2.i11.40721160904
   PubMed Web of Science ®Google Scholar
• Razumilava N, Gores GJ. Cholangiocarcinoma. Lancet. 2014;383(9935):2168–2179. doi:10.1016/S0140-6736(13)61612-824581682
   PubMed Web of Science ®Google Scholar
• Nathan H, Pawlik TM, Wolfgang CL, Cameron JL, Schulick RD, Schulick RD. Trends in survival after surgery for cholangiocarcinoma: a 30-year population-based SEER database analysis. J Gastrointest Surg. 2007;11:1488–1496. doi:10.1007/s11605-007-0282-017805937
   PubMed Web of Science ®Google Scholar
• Mavros MN, Economopoulos KP, Alexiou VG, Pawlik TM. Treatment and prognosis for patients with intrahepatic cholangiocarcinoma: systematic review and meta-analysis. JAMA Surg. 2014;149:565–574. doi:10.1001/jamasurg.2013.513724718873
   PubMed Web of Science ®Google Scholar
• Kerr SE, Barr Fritcher EG, Campion MB, et al. Biliary dysplasia in primary sclerosing cholangitis harbors cytogenetic abnormalities similar to cholangiocarcinoma. Hum Pathol. 2014;45(9):1797–1804. doi:10.1016/j.humpath.2014.05.00825027853
   PubMed Web of Science ®Google Scholar
• Seol SY, Kim C, Lim JY, et al. Overexpression of endoplasmic reticulum oxidoreductin 1-α (ERO1A) is associated with poor prognosis of gastric cancer. Cancer Res Treat. 2016;48(4):1196–1209. doi:10.4143/crt.2015.18926987398
   PubMed Web of Science ®Google Scholar
• Masui S, Vavassori S, Fagioli C, Sitia R, Inaba K. Molecular bases of cyclic and specific disulfide interchange between human ERO1α Protein and Protein-disulfide Isomerase (PDI). J Biol Chem. 2011;286(18):16261. doi:10.1074/jbc.M111.23135721398518
   PubMed Web of Science ®Google Scholar
• Araki, Kazutaka, Kazuhiro Nagata. Functional in vitro analysis of the ERO1 protein and protein-disulfide isomerase pathway. J Biol Chem. 2011;286(37):32705–32712. doi:10.1074/jbc.M111.22718121757736
   PubMed Web of Science ®Google Scholar
• Periyasamy P, Guo ML, Buch S, et al. Cocaine induces astro-cytosis through ER stress-mediated activation of autophagy. Autophagy. 2016;12:1310–1329. doi:10.1080/15548627.2016.118384427337297
   PubMed Web of Science ®Google Scholar
• Zhang ZZ, Yuan K, Yue HT, et al. Identification and functional characterization of an endoplasmic reticulum oxidoreductin 1-α gene in litopenaeus vannamei. Dev Comp Immunol. 2016;57:10–19. doi:10.1016/j.dci.2015.11.01326631649
   PubMed Web of Science ®Google Scholar
• Kutomi G, Tamura Y, Tanaka T, et al. Human endoplasmic reticulum oxidoreductin 1-a is a novel predictor for poor prognosis of breast cancer. Cancer Sci. 2013;104:1091–1096. doi:10.1111/cas.1217723578220
   PubMed Web of Science ®Google Scholar
• Takei N, Yoneda A, Sakai-Sawada K, Kosaka M, Minomi K, Tamura Y. Hypoxia-inducible ERO1α promotes cancer progression through modulation of integrin-β1 modification and signalling in HCT116 colorectal cancer cells. Sci Rep. 2017;7(1):9389. doi:10.1038/s41598-017-09976-728839225
   PubMedGoogle Scholar
• Li G, Mongillo M, Chin KT, et al. Role of ERO1-alpha-mediated stimulation of inositol 1,4,5-triphosphate receptor activity in endoplasmic reticulum stress-induced apoptosis. J Cell Biol. 2009;186(6):783–792. doi:10.1083/jcb.20090406019752026
   PubMed Web of Science ®Google Scholar
• Sugawara H, Yasoshima M, Katayanagi K, et al. Relationship between interleukin-6 and proliferation and differentiation in cholangiocarcinoma. Histopathology. 1998;33:145–153. doi:10.1046/j.1365-2559.1998.00445.x9762547
   PubMed Web of Science ®Google Scholar
• Jin T, Kim HS, Choi SK, et al. microRNA-200c 141 upregulates serpinB2 to promote breast cancer cell metastasis and reduce patient survival. Oncotarget. 2017;8(20):32769–32782. doi:10.18632/oncotarget.1568028427146
   PubMedGoogle Scholar
• Brabletz T. To differentiate or not–routes towards metastasis. Nat Rev Cancer. 2012;12(6):425–436. doi:10.1038/nrc326522576165
   PubMed Web of Science ®Google Scholar
• Diepenbruck M, Christofori G. Epithelial-mesenchymal transition (EMT) and metastasis: yes, no, maybe? Curr Opin Cell Biol. 2016;43:7–13. doi:10.1016/j.ceb.2016.06.00227371787
   PubMed Web of Science ®Google Scholar
• Baoyu L, Yang J, Lu Z, Liu B, Liu F. A study on the mechanism of rapamycin mediating the sensitivity of pancreatic cancer cells to cisplatin through PI3K/AKT/mTOR signaling pathway. J Buon. 2019;24(2):739–745.31128031
   PubMed Web of Science ®Google Scholar
• Li H, Wang X, Fang Y, et al. Integrated expression profiles analysis reveals novel predictive biomarker in pancreatic ductal adenocarcinoma. Oncotarget. 2017;8(32):52571–52583.28881752
   PubMedGoogle Scholar
• Chen CY, Shiesh SC, Tsao HC, Lin X-Z. The assessment of biliary CA 125, CA 19-9 and CEA in diagnosing cholangiocarcinoma–the influence of sampling time and hepatolithiasis. Hepatogastroenterology. 2002;49:616–620.12063953
   PubMedGoogle Scholar
• Maestranzi S, Przemioslo R, Mitchell H, Sherwood RA. The effect of benign and malignant liver disease on the tumour markers CA19-9 and CEA. Ann Clin Biochem. 1998;35(Pt 1):99–103. doi:10.1177/0004563298035001139463746
   PubMedGoogle Scholar
• Loosen SH, Roderburg C, Kauertz KL, et al. CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma. Sci Rep. 2017;7(1):16975. doi:10.1038/s41598-017-17175-729208940
   PubMed Web of Science ®Google Scholar
• Sapisochin G, Facciuto M, Rubbia-Brandt L, et al. Liver transplantation for “very early” intrahepatic cholangiocarcinoma: international retrospective study supporting a prospective assessment. Hepatology. 2016;64:1178–1188. doi:10.1002/hep.2874427481548
   PubMed Web of Science ®Google Scholar
• Rizvi S, Gores GJ. Emerging molecular therapeutic targets for cholangiocarcinoma. J Hepatol. 2017;67(3):632–644. doi:10.1016/j.jhep.2017.03.02628389139
   PubMed Web of Science ®Google Scholar
• Zhang Y, Li T, Zhang L, et al. Targeting the functional interplay between endoplasmic reticulum oxidoreductin-1α and protein disulfide isomerase suppresses the progression of cervical cancer. EBioMedicine. 2019;41:408–419. doi:10.1016/j.ebiom.2019.02.04130826359
   PubMed Web of Science ®Google Scholar
• Tanaka T, Kutomi G, Kajiwara T. Cancer-associated oxidoreductase ERO1-α drives the production of VEGF via oxidative protein folding and regulating the mRNA level. Br J Cancer. 2016;114(11):1227–1234.27100727
   PubMed Web of Science ®Google Scholar
• Ke A, Shi G, Zhou J, et al. CD151 amplifies signaling by integrin α6β1 to PI3K and induces the epithelial–mesenchymal transition in HCC cells. Gastroenterology. 2011;140(5):1629–1641. doi:10.1053/j.gastro.2011.02.00821320503
   PubMed Web of Science ®Google Scholar
• Ding W, You H, Dang H, et al. Epithelial-to-mesenchymal transition of murine liver tumor cells promotes invasion. Hepatology. 2010;52(3):945–953. doi:10.1002/hep.2374820564331
   PubMed Web of Science ®Google Scholar
• Joseph JP, Harishankar MK, Pillai AA, Devi A. Hypoxia induced EMT: a review on the mechanism of tumor progression and metastasis in OSCC. Oral Oncol. 2018;80(May 2018):23. doi:10.1016/j.oraloncology.2018.03.00429706185
   PubMedGoogle Scholar
• Sun S, Ning X, Zhang Y, et al. Hypoxia-inducible factor-1α induces twist expression in tubular epithelial cells subjected to hypoxia, leading to epithelial-to-mesenchymal transition. Kidney Int. 2009;75(12):1278–1287. doi:10.1038/ki.2009.6219279556
   PubMed Web of Science ®Google Scholar
• Liu Z, Tu K, Wang Y, et al. Hypoxia accelerates aggressiveness of hepatocellular carcinoma cells involving oxidative stress, epithelial-mesenchymal transition and non-canonical hedgehog signaling. Cell Physiol Biochem. 2017;44(5):1856. doi:10.1159/00048582129237157
   PubMedGoogle Scholar
• Lin HL, Yang MH, Wu CW, et al. 2-Methoxyestradiol attenuates phosphatidylinositol 3-kinase/Akt pathway-mediated metastasis of gastric cancer. Int J Cancer. 2007;121(11):2547–2555. doi:10.1002/ijc.2286117680560
   PubMed Web of Science ®Google Scholar
• Ke F, Wang Z, Song X, et al. Cryptotanshinone induces cell cycle arrest and apoptosis through the JAK2/STAT3 and PI3K/Akt/NFκB pathways in cholangiocarcinoma cells. Drug Des Devel Ther. 2017;11:1753–1766. doi:10.2147/DDDT.S132488
   PubMed Web of Science ®Google Scholar